Is this high-return, lightly regulated asset class too good to be true? Top financial voices are warning of a potential ...

Chair of UBS Colm Kelleher repeatedly referred to the deal as either an “integration” or “transaction.” Kelleher said the merger would “enhance the combined organization's ability to ...

China's Vice-Premier He Lifeng, the government's top man on the financial industry, is scheduled to lead a delegation of senior bankers and officials to Hong Kong next week for the third annual ...

UBS Group AG has made a string of investment banking leadership changes following some senior departures as the Swiss lender seeks to bolster areas such as health care and leveraged finance ...

We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, we will look at where APA Corporation (NASDAQ:APA) ranks on the list ...

Mumbai, 12 Nov 2024 – UBS announces today the commencement of the UBS India Summit, running from November 11 to 15, 2024, marking over two decades of this pivotal event in the financial sector. This ...

Zurich, 8 November 2024 – UBS AG today published its third-quarter 2024 financial report and Pillar 3 report. UBS Group AG previously reported its third-quarter results on a consolidated basis on 30 ...

UBS launched its coverage of Sagimet Biosciences (NASDAQ:SGMT) with a buy recommendation and a $12 price target, calling the company an underappreciated player in the market for liver disorder ...

ZURICH/FRANKFURT/LONDON (Reuters) - The United States is pursuing an inquiry into Russian clients that UBS took on when it bought Credit Suisse, three people familiar with the matter said ...

UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The company’s shares closed yesterday at $26.72. Huynh covers the ...